| Lonza Group AG | 549.40 |
| Date/Time | 05/25 / 17:19 |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | 554.40 |
| Previous Close | 556.20 |
| High | 556.60 |
| Low | 546.60 |
| Volume [CHF] | 15,170,580.80 |
| Volume [Units] | 27,583 |
| Price fixings | 2610 |
| ISIN | CH0013841017 |
| Security | LONN/Z |
| Exchange | Cboe Europe CXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Nasdaq Other.. | 565.8270 |  |
10 |
| Lang & Schwa.. | 528.400 |  |
|
| SIX Swiss Ex.. | 547.80 | |
|
| Cboe Europe .. | 549.40 | 27,583 | |
| London Domes.. | 547.80 | 17,759 | |
| Cboe Europe .. | 547.80 | 12,369 | |
| Turquoise | 549.80 | |
3,740 |
| Mexico | 11,590.38 | |
295 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration
11/02/2021 / 13:00 - GlobeNewswire - Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment of Neurologic and Neuro-oncologic Diseases supported by Multi-Year Manufacturing Agreement with Lonza Group
09/08/2021 / 13:30 - GlobeNewswire - aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
04/14/2021 / 14:00 - GlobeNewswire - Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
03/12/2021 / 07:00 - GlobeNewswire - Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire
Real-time